US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

210.00

-17.7500-7.79%

Volume:385.17K

Turnover:82.54M

Market Cap:530.14M

PE:- -

High:223.71

Open:220.01

Low:208.99

Close:227.75

52wk High:341.93

52wk Low:102.35

Shares:2.52M

Float Shares:2.52M

Volume Ratio:2.02

T/O Rate:15.26%

Dividend:0.91

Dividend Rate:0.43%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Movement Alert｜Direxion Daily S&P Biotech Bull 3x Shares Falls 8.24% in Regular Trading, Leveraged Biotech Pressured by Rate Expectations

Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Edgewise Therapeutics (EWTX)

Healthcare Realty Trust Showing Solid Progress on 2.0 Plan, RBC Says

MT Newswires Live

AbbVie (ABBV) Lands Two FDA Breakthrough Tags For Temab A In Cancer

Simply Wall St.

Lepu Medical's Subsidiary Gains FDA Clearance for Clinical Trial of MWN117 Injection

Biofrontera submits sNDA to FDA to expand Ameluz indication

Shenzhen Lifotronic Technology's H100Plus Hemoglobin Testing System Receives FDA 510(k) Clearance

Virtuix to Showcase AI-Driven Full-Body Simulation Platform Across Defense, Humanoid Robotics, and Healthcare at LD Micro Main Event

Vir Biotechnology gains FDA Fast Track for VIR-5500

Is Ping An Healthcare and Technology (SEHK:1833) A Bargain As Valuation Signals Diverge?

Simply Wall St.

Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)

Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026

Press Release: Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

Kingdomway's Subsidiary Receives FDA GRAS No Objection Letter for Brazzein Sweet Protein Product

Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell

MT Newswires Live

EPF lifts stake in IHH Healthcare to 13.3% via fresh share acquisitions

Perspective Therapeutics Wins FDA Fast Track for PSV359

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Connect Biopharma Holdings (CNTB) and Helus Pharma (HELP)

Humanwell Healthcare's Subsidiary Secures FDA Approval for Diltiazem Hydrochloride Tablets

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and Chemed (CHE)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":210,"timestamp":1791474639308,"preClose":227.75,"halted":0,"volume":385170,"delay":0,"changeRate":-0.07793633369923161,"floatShares":2524486,"shares":2524486,"eps":0,"marketStatus":"Trading","change":-17.75,"latestTime":"10-08 11:50:47 EDT","open":220.01,"high":223.7074,"low":208.985,"amount":82538483.72850001,"amplitude":0.064643,"askPrice":209.44,"askSize":40,"bidPrice":209,"bidSize":18,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":227.75,"sharesOutstanding":3074486,"nav":230.529,"aum":581967299.18,"dividendRate":0.004338,"bidAskSpread":0.002401,"preHourTrading":{"tag":"盘前","latestPrice":220.18,"preClose":227.75,"latestTime":"09:29 EDT","volume":6169,"amount":1385605.45651,"timestamp":1791466199999,"change":-7.57,"changeRate":-0.033238,"amplitude":0.038727},"postHourTrading":{"tag":"盘后","latestPrice":228.7,"preClose":227.75,"latestTime":"19:59 EDT","volume":2729,"amount":623483.6155,"timestamp":1791417573520,"change":0.95,"changeRate":0.004171,"amplitude":0.004911},"volumeRatio":2.019871,"impliedVol":0.9577,"impliedVolPercentile":0.6693},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2524486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.019871,"shares":2524486,"dividePrice":0.911,"high":223.7074,"amplitude":0.064643,"preClose":227.75,"low":208.985,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":210,"committee":-0.37931,"eps":0,"divideRate":0.004338,"volume":385170,"delay":0,"ttmEps":0,"open":220.01,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":249.65,"twentyDayClose":266,"sixtyDayClose":277.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1134548888","title":"Movement Alert｜Direxion Daily S&P Biotech Bull 3x Shares Falls 8.24% in Regular Trading, Leveraged Biotech Pressured by Rate Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1134548888","media":"Market Focus","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1134548888?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:39","pubTimestamp":1791473993,"startTime":"0","endTime":"0","summary":"On October 8, Direxion Daily S&P Biotech Bull 3x Shares fell 8.24% in regular trading, trading at $209.175 per share, with turnover of $81.3021 million.The fund provides triple leveraged exposure to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Leveraged Biotech Plunges as Rate Hike Fears Hit Sector","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673062510","title":"Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Edgewise Therapeutics (EWTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673062510","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673062510?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:20","pubTimestamp":1791472813,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se (ARGX) and Edgewise Therapeutics (EWTX) wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-argenx-se-argx-edgewise-therapeutics-ewtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-argenx-se-argx-edgewise-therapeutics-ewtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","HCSG","BK4588","LU0320765992.SGD","LU0889565916.HKD","LU1983260115.SGD","BK4007","LU0029874061.USD","LU0109394709.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4139","LABU","BK4581","FMED","LU0823416689.USD","XLV","IBB","LU2324357040.USD","IE00BFTCPJ56.SGD","LU0390134368.USD","BK4505","IE0034235188.USD","IE0002141913.USD","IE0009355771.USD","TBXU","BK4137","BK4539","XBI","LU0128526141.USD","ARGX","BK4585","EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673727005","title":"Healthcare Realty Trust Showing Solid Progress on 2.0 Plan, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2673727005","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673727005?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:56","pubTimestamp":1791471396,"startTime":"0","endTime":"0","summary":"Healthcare Realty Trust  is making steady progress on its strategic plan and remains on track to reach its targeted funds-from-operations run-rate ahead of schedule, with recent debt refinancing likely lifting the lower end of that range, RBC Capital Markets said Thursday in a report.Phase I of HR 2.0, focused on fixing systems, is complete, marked by a rebuilt operating team, a workable asset-management model, a stronger balance sheet and clearer audience targeting, RBC said after meeting with company executives.Phase II, centered on execution, is underway as the company deepens its health-system relationships, driving better leasing results and higher tenant retention, the report said.Phase III, aimed at fueling growth, has begun as the company evaluates incremental investment opportunities, the report said. This backdrop supports a three-year FFO run-rate of $1.65 to $1.85, and once achieved, the plan should allow mid-single-digit FFO growth, RBC said.RBC maintained its sector-perfo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SRET","BK4225","BK4097","LABU","LU2065732104.USD","HR","BK4137","LU0128526141.USD","BK4585","XBI","BK4581","XLV","PRGS","LU0029874061.USD","BK4203","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673067440","title":"AbbVie (ABBV) Lands Two FDA Breakthrough Tags For Temab A In Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673067440","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673067440?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:42","pubTimestamp":1791470551,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE:ABBV) received two FDA Breakthrough Therapy Designations for telisotuzumab adizutecan, also known as Temab-A.\nThe designations cover treatment of colorectal cancer and non small cell lung cancer, both high unmet need tumor types.\nThese are the first Breakthrough Therapy Designations granted for Temab-A within AbbVie's growing antibody drug conjugate portfolio.\nThe twin FDA Breakthrough Therapy Designations for Temab-A in colorectal and lung cancer connect to a wider picture our...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-lands-two-fda-breakthrough-tags-for-temab-a-in-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-lands-two-fda-breakthrough-tags-for-temab-a-in-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FHLC","IE00B19Z3581.USD","BK4559","LU0859254822.USD","LU0708994859.HKD","VHT","LU0289961442.SGD","LU0965508806.USD","LU1061106388.HKD","LU2089984988.USD","PJP","LU1548497426.USD","LU0553294199.USD","LU1093756325.SGD","LU1934455277.USD","TRUH","XLV","LU2087621335.USD","AGNG","IE00B19Z3B42.SGD","LU2357627491.SGD","RXL","SG9999003800.SGD","LU2129689605.HKD","GLAM","LU1720051017.SGD","LU0985320562.USD","IXJ","LU2347655156.SGD","LU1074936037.SGD","BK4533","LU0124676726.USD","IE000MB6IJN5.SGD","LABU","LU0861579265.USD","LU0726765562.USD","JDOC","LU2089283258.USD","LU0310799852.SGD","LU1057294990.SGD","FTXH","IYH","MEDX","LU1244550494.USD","LU0689626769.HKD","ABBV","LU1093756168.USD","LU1983299246.USD","LU1162221912.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182207516","title":"Lepu Medical&#39;s Subsidiary Gains FDA Clearance for Clinical Trial of MWN117 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1182207516","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182207516?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:52","pubTimestamp":1791467534,"startTime":"0","endTime":"0","summary":"Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ) announced today that its controlling subsidiary, Shanghai Minwei Biotechnology Co., Ltd., has received a Study May Proceed Letter from the U.S....","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BK0028","300003","BK0042","BMED","BK4585","BK0188","BK0196","BK4588","IBBQ","BK0251","LABU","BK0113","IBBJ","BK0201","MDTX","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673008501","title":"Biofrontera submits sNDA to FDA to expand Ameluz indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2673008501","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673008501?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:37","pubTimestamp":1791466668,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that it has submitted a supplemental new drug application, or sNDA, to the FDA to expand the indication for Ameluz top...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-submits-snda-to-fda-to-expand-ameluz-indication-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-submits-snda-to-fda-to-expand-ameluz-indication-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585","BK4007","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191718731","title":"Shenzhen Lifotronic Technology's H100Plus Hemoglobin Testing System Receives FDA 510(k) Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=1191718731","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191718731?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:26","pubTimestamp":1791465969,"startTime":"0","endTime":"0","summary":"Shenzhen Lifotronic Technology Co.,Ltd. (688389.SH) has announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that its H100Plus hemoglobin testing system...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","BK4588","688389","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673003816","title":"Virtuix to Showcase AI-Driven Full-Body Simulation Platform Across Defense, Humanoid Robotics, and Healthcare at LD Micro Main Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2673003816","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673003816?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:17","pubTimestamp":1791465420,"startTime":"0","endTime":"0","summary":"Live Omni One Demonstration to Accompany Investor Presentation and One-on-One Meetings Presentation Follows 3X Omni One Order Growth and Expanding Adoption Across U.S. Government and Enterprise Market","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/08/3377366/0/en/virtuix-to-showcase-ai-driven-full-body-simulation-platform-across-defense-humanoid-robotics-and-healthcare-at-ld-micro-main-event.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","VTIX","BK4588","BK4581","BK4170","XLV","ROBO","QTOC","LU0128526141.USD","LABU","ARTY","BOTZ","XBI","AIPO","BK4585","HCSG","VTHR","LU0029874061.USD","CHAT","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673077045","title":"Vir Biotechnology gains FDA Fast Track for VIR-5500","url":"https://stock-news.laohu8.com/highlight/detail?id=2673077045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673077045?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:58","pubTimestamp":1791464310,"startTime":"0","endTime":"0","summary":"Vir Biotechnology ( ($VIR) ) has shared an announcement. On October 6, 2026, Vir Biotechnology announced that the U.S. Food and Drug Administration...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vir-biotechnology-gains-fda-fast-track-for-vir-5500?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vir-biotechnology-gains-fda-fast-track-for-vir-5500?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VIR","LABU","BK4535","BK4568","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673003676","title":"Is Ping An Healthcare and Technology (SEHK:1833) A Bargain As Valuation Signals Diverge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673003676","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673003676?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:32","pubTimestamp":1791462764,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology (SEHK:1833) has drawn fresh attention after recent share performance, with the stock down 8% over the past month and about 21% over the past 3 months.\nAt a share price of HK$5.96, Ping An Healthcare and Technology has not only slipped over the past month, it has also seen its 1-year total shareholder return decline 66.12%, which signals fading momentum as investors reassess both growth prospects and risk.\nCompare Ping An Healthcare and Technology's slide with...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-a-bargain-as-v","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-a-bargain-as-v","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","BK4588","HCSG","XBI","BK4137","LU0128526141.USD","BK1219","BK4581","01833","BK1515","BK1142","XLV","BK1571","BK1617","BK1615","LU0029874061.USD","BK4585","BK1247","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673133072","title":"Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673133072","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673133072?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:10","pubTimestamp":1791461430,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and Rhythm Pharmaceuticals (R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-gilead-sciences-gild-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-gilead-sciences-gild-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GILD","IBB","LU0234570918.USD","LU0965508806.USD","BK4585","LU0882574055.USD","LU0965509010.AUD","LU1674673428.USD","IE00B3T34201.USD","LU1934455277.USD","LU2357627491.SGD","TMED","BK4583","IE00BZ1G4Q59.USD","LU1934455863.HKD","XBI","LU2324357040.USD","TBXU","LU2468319806.SGD","IE00B19Z3581.USD","BK4137","LU0058720904.USD","LU1023059063.AUD","LU2112291526.USD","LU2089984988.USD","IE00B7SZLL34.SGD","BIB","IE0002270589.USD","BK4568","LABU","SG9999015986.USD","BK4566","LU0029874061.USD","LU0965509283.SGD","LU1066053197.SGD","SG9999015978.USD","LU0965509101.SGD","MEDI","LU1037948897.HKD","LU0823416689.USD","XLV","IE00B19Z3B42.SGD","BBH","BK4532","LU0320765992.SGD","HCSG","RYTM","IBBQ","BMED","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673072619","title":"Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673072619","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673072619?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"Preliminary revenue of $2.3 million represents the highest quarterly revenue reported, and approximately 30% sequential quarterly growth and 27% growth over the same period last year Performance refle","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/08/3377217/0/en/beyond-air-preannounces-preliminary-revenue-for-the-quarter-ended-september-30-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAIR","LABU","BK4585","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673007412","title":"Press Release: Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673007412","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673007412?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"NEWTON, Mass.--(BUSINESS WIRE)--October 08, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per sh","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","DHC","BK4203","BK4581","BK4225","XBI","BK4588","HAUS","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114859472","title":"Kingdomway's Subsidiary Receives FDA GRAS No Objection Letter for Brazzein Sweet Protein Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1114859472","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114859472?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:58","pubTimestamp":1791457108,"startTime":"0","endTime":"0","summary":"Xiamen Kingdomway Group Company (002626.SZ) has announced that its wholly-owned subsidiary, Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. (\"Kingdomway Pharmaceutical\"), recently received a no...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002626","BK0197","BK4585","BK0077","159100","BK4588","BK0226","BK0191","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673407600","title":"Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2673407600","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673407600?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:53","pubTimestamp":1791456799,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics  said Thursday that the US Food and Drug Administration, or FDA, granted fast track designation for the development of PSV359, an experimental cancer treatment for adults with advanced tumors that cannot be removed through surgery or have spread to other parts of the body.The investigational therapy is being studied in an ongoing Phase 1/2a trial in patients with advanced fibroblast activation protein-positive solid tumors, the company said.The company said early human imaging data showed strong tumor uptake and rapid kidney clearance for PSV359.The FDA's fast track program is aimed at accelerating the development and review of therapies for serious conditions with unmet medical needs, the company added.Shares rose around 4.9% in premarket trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4139","BK4585","CATX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673079644","title":"EPF lifts stake in IHH Healthcare to 13.3% via fresh share acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2673079644","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673079644?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:51","pubTimestamp":1791456679,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) has provided an announcement. Malaysia’s Employees Provident Fund Board has increased its direct stake in IHH Healt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-lifts-stake-in-ihh-healthcare-to-13-3-via-fresh-share-acquisitions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-lifts-stake-in-ihh-healthcare-to-13-3-via-fresh-share-acquisitions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4581","BK4585","BK4588","XLV","LABU","LU0029874061.USD","XBI","LU0128526141.USD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673079980","title":"Perspective Therapeutics Wins FDA Fast Track for PSV359","url":"https://stock-news.laohu8.com/highlight/detail?id=2673079980","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673079980?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:48","pubTimestamp":1791456486,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics ( ($CATX) ) has issued an update. On October 8, 2026, Perspective Therapeutics announced that the U.S. Food and Drug Admin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/perspective-therapeutics-wins-fda-fast-track-for-psv359?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/perspective-therapeutics-wins-fda-fast-track-for-psv359?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","CATX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673076180","title":"Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Connect Biopharma Holdings (CNTB) and Helus Pharma (HELP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673076180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673076180?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:30","pubTimestamp":1791455457,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mirum Pharmaceuticals (MIRM), Connect Biopharma Hold...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mirum-pharmaceuticals-mirm-connect-biopharma-holdings-cntb-and-helus-pharma-help-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mirum-pharmaceuticals-mirm-connect-biopharma-holdings-cntb-and-helus-pharma-help-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4137","XBI","LABU","MIRM","BK4139","LU0029874061.USD","CNTB","BK4007","HCSG","BK4585","LU0128526141.USD","HELP","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125924715","title":"Humanwell Healthcare's Subsidiary Secures FDA Approval for Diltiazem Hydrochloride Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1125924715","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125924715?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:38","pubTimestamp":1791452288,"startTime":"0","endTime":"0","summary":"Humanwell Healthcare (Group) Co., Ltd. (ASX: 600079.SH) announced that its controlling subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (Yichang Humanwell), has received approval from the U.S....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","600079","BK0070","BK0028","BK0012","BK4585","LABU","BK0096","BK0239","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673207450","title":"Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and Chemed (CHE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673207450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673207450?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:10","pubTimestamp":1791450618,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Rocket Pharmaceuticals (RCKT) and Chemed (CHE). Ro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rocket-pharmaceuticals-rckt-and-chemed-che-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rocket-pharmaceuticals-rckt-and-chemed-che-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1165135440.EUR","LU0029874061.USD","LU1543694498.USD","XBI","LU2413665964.HKD","IE00B64QTZ34.USD","BK4137","LU1721427968.SGD","IE00BLDYK493.USD","LU1620156213.USD","RCKT","LU0128526141.USD","BK4581","BK4139","CHE","BK4196","LABU","LU1620156130.USD","XLV","BK4585","LU1596574779.USD","LU2413666004.HKD","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":1,"totalSize":422,"code":"91000000","status":"200"}]}}